SCHEMBL336442

SCHEMBL336442

CC(C)[Si](C#Cc1c2cc3ccccc3cc2c(C#C[Si](C(C)C)(C(C)C)C(C)C)c2cc3ccccc3cc12)(C(C)C)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA2D1 P54289 1/20 0.37
CACNB2 Q08289 1/20 0.37
CACNA1C Q13936 1/20 0.37
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 2/20 0.35
LMNA P02545 1/20 0.35
NQO1 P15559 1/20 0.34
MAPT P10636 3/20 0.33
CYP1A2 P05177 2/20 0.33
CYP1B1 Q16678 2/20 0.33
CYP1A1 P04798 1/20 0.33
UGT2B7 P16662 1/20 0.32
GAA P10253 2/20 0.31
ALDH1A1 P00352 2/20 0.31
ELANE P08246 1/20 0.31
NPC1 O15118 1/20 0.31
USP2 O75604 1/20 0.31
GLA P06280 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29360481 1.00 CACNA2D1 (0.37) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL18267813 0.98 CACNA2D1 (0.36) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL1270205 0.96 CACNA2D1 (0.35) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL30360377 0.96 CACNA2D1 (0.35) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL20044956 0.96 CACNA2D1 (0.35) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL14514097 0.96 CACNA2D1 (0.35) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL651091 0.93 CACNA2D1 (0.33) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL27725041 0.93 CACNA2D1 (0.35) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL17165996 0.92 CACNA2D1 (0.33) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10
SCHEMBL17231135 0.92 CACNA2D1 (0.36) CACNA2D1CACNB2CACNA1CKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 906 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130039-A1 LOW-VOLTAGE ORGANIC LIGHT-EMITTING SYNAPSE ELEMENT AND STIMULUS-SENSITIVE NEUROMORPHIC DISPLAY DEVICE COMPRISING SAME SEOUL NAT UNIV R&DB FOUNDATION (KR) 2026-05-07 US claimed
US-20250298158-A1 X-RAY SENSING PANEL AND X-RAY SENSING DEVICE, METHOD OF USING THE SAME AND METHOD OF FORMING SEMICONDUCTOR STRUCTURE INCLUDING THE SAME NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) 2025-09-25 US claimed
US-12414462-B2 Organic single crystal composite oriented polymer membrane, preparation method therefor, optoelectronic device and application thereof ZHEJIANG UNIVERSITY (CN) 2025-09-09 US claimed
US-20250120305-A1 ORGANIC SINGLE CRYSTAL COMPOSITE ORIENTED POLYMER MEMBRANE, PREPARATION METHOD THEREFOR, OPTOELECTRONIC DEVICE AND APPLICATION THEREOF ZHEJIANG UNIVERSITY (CN) 2025-04-10 US claimed
WO-2025019949-A1 ORGANIC ELECTROLYTE-GATED FIELD EFFECT TRANSISTOR BIOSENSOR CARLETON UNIVERSITY (CA) 2025-01-30 WO claimed
US-20240337544-A1 THREE-DIMENSIONALLY STACKED MULTI-MODAL SENSOR FOR SIMULTANEOUSLY DETECTING PRESSURE AND TEMPERATURE AND METHOD OF MANUFACTURING SAME POSTECH Research and Business Development Foundation (KR) 2024-10-10 US claimed
WO-2024187552-A1 THIN FILM COMPOSITING ORGANIC SINGLE CRYSTAL AND ORIENTED POLYMER, PREPARATION METHOD, AND PHOTOELECTRIC DEVICE AND USE 浙江大学 2024-09-19 WO claimed
WO-2024088117-A1 MXENE-BASED CONDUCTIVE INK HAVING ADJUSTABLE WORK FUNCTION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN THIN FILM TRANSISTORS 郑州大学 2024-05-02 WO claimed
WO-2023224434-A1 LOW-VOLTAGE ORGANIC LIGHT-EMITTING SYNAPSE ELEMENT AND STIMULUS-SENSITIVE NEUROMORPHIC DISPLAY DEVICE COMPRISING SAME 서울대학교산학협력단 2023-11-23 WO claimed
WO-2023158277-A1 ORGANOSILICON-ORGANIC SEMICONDUCTOR COMPOSITE AND ORGANIC SEMICONDUCTOR FILM INCLUDING SAME 한양대학교 산학협력단 2023-08-24 WO claimed
WO-2007078993-A1 BOTTOM GATE THIN FILM TRANSISTORS 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-07-12 WO claimed
WO-2007078860-A1 ALL-INKJET PRINTED THIN FILM TRANSISTOR 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-07-12 WO claimed
US-20070158643-A1 BOTTOM GATE THIN FILM TRANSISTORS 3M INNOVATIVE PROPERTIES COMPANY 2007-07-12 US claimed
US-20070146426-A1 ALL-INKJET PRINTED THIN FILM TRANSISTOR 3M INNOVATIVE PROPERTIES COMPANY 2007-06-28 US claimed
US-20070102696-A1 Organic semiconducting layers FLEXENABLE TECHNOLOGY LIMITED (GB) 2007-05-10 US claimed
WO-2007039575-A1 LIQUID PHASE FABRICATION OF ACTIVE DEVICES INCLUDING ORGANIC SEMICONDUCTORS BASF SE (DE) 2007-04-12 WO claimed
US-20070077681-A1 Liquid phase fabrication of active devices including organic semiconductors ALCATEL-LUCENT USA INC. 2007-04-05 US claimed
EP-1687830-A2 ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS Merck Patent GmbH (DE) 2006-08-09 EP claimed
WO-2005055248-A2 ORGANIC SEMICONDUCTING LAYER FORMULATIONS COMPRISING POLYACENES AND ORGANIC BINDER POLYMERS MERCK PATENT GMBH (DE) 2005-06-16 WO claimed
US-6690029-B1 Substituted pentacenes and electronic devices made with substituted pentacenes UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2004-02-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070102696-A1 Organic semiconducting layers SSB, RCOR3, CNKSR1 CACNA2D1 4076/4885CACNB2 2597/4885CACNA1C 3289/4885
US-20260130039-A1 LOW-VOLTAGE ORGANIC LIGHT-EMITTING SYNAPSE ELEMENT AND STIMULUS-SENSITIVE NEUROMORPHIC DISPLAY DEVICE COMPRISING SAME L1CAM, HCN3, NCS1 CACNA2D1 80/4885CACNB2 123/4885CACNA1C 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.